Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Clinical Pharmacology|December 13, 2021
Evaluation of the Pharmacokinetics and Safety of a Single Dose of Acalabrutinib in Subjects With Hepatic ImpairmentYan Xu, Raquel Izumi, Helen Nguyen, et al.Therapeutic Advances in Hematology|June 5, 2023
Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemiaWojciech Jurczak, Nagah Elmusharaf, Christopher P Fox, et al.Clinical Pharmacology in Drug Development|August 27, 2022
Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton-Pump InhibitorsShringi Sharma, Xavier Pepin, Harini Burri, et al.American Journal of Obstetrics and Gynecology|May 31, 2011
Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestationSteve N Caritis, Shringi Sharma, Raman Venkataramanan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2024
A Phase 1 First-in-Human Study of the MCL-1 Inhibitor AZD5991 in Patients with Relapsed/Refractory Hematologic MalignanciesPinkal Desai, Sagar Lonial, Amanda Cashen, et al.Hepatology (Baltimore, Md.)|March 5, 2011
Hepatic differentiation of amniotic epithelial cellsFabio Marongiu, Roberto Gramignoli, Kenneth Dorko, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2023
Phase I Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker AssessmentMark Roschewski, Manish R Patel, Patrick M Reagan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2023
Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell LymphomaJulio C Chavez, Francine M Foss, Basem M William, et al.Pageof 4